Purdue, Sackler Family Reach New $7.4 Billion Opioid Accord (2)

Jan. 23, 2025, 6:31 PM UTC

Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the deadly opioid epidemic.

The deal comes after the US Supreme Court last year rejected a $6 billion pact that would have protected Purdue’s owners, members of the billionaire Sackler family, from any further litigation related to the addiction crisis. Thursday’s settlement in principle doesn’t give the family automatic protection from future litigation, New York Attorney General Letitia James said in a statement.

The accord is the latest twist ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.